Document ID: chunk:federal_register_of_legislation:C2025C00090:section:99acc:p3
Version: federal_register_of_legislation:C2025C00090
Segment Type: section
Provision Reference: s 99ACC (pt 3/3)
Character Range: 336283–338700

(b) determinations under section 85B;
for the single brand of the combination item.

Subject to statutory price reduction etc.
 (6) The following provisions have effect:
 (a) a listed component drug contained in a drug in a combination item becomes subject to statutory price reduction if section 99ACB or 99ACQ or subsection 99ACR(3) or (4) or section 99ADH has applied to a listed brand of a pharmaceutical item that:
 (i) has the listed component drug; and
 (ii) has the same manner of administration as the combination item;
 (b) whichever provision mentioned in paragraph (a) applied, that provision applies to the listed component drug contained in the drug in the combination item in the same way as that provision applies to the listed brand of the pharmaceutical item that:
 (i) has the listed component drug; and
 (ii) has the same manner of administration as the combination item;
 (c) a listed component drug contained in a drug in a combination item becomes subject to statutory price reduction if subsection 99ACF(1) or (2) because of an item in the table in section 99ACF has applied to a listed brand of a pharmaceutical item that has the listed component drug;
 (d) whichever provision mentioned in paragraph (c) applied, that provision applies to the listed component drug contained in the drug in the combination item in the same way as that provision applies to the listed brand of the pharmaceutical item that has the listed component drug.

Modified meaning of the same manner of administration
 (7) For the purposes of subsection (6), a combination item whose drug contains a listed component drug has the same manner of administration as another pharmaceutical item that has (or whose drug contains) the listed component drug if the manner of administration set out in a determination under subsection 85(5) for the combination item, to the extent that the manner of administration relates to the listed component drug:
 (a) if the other pharmaceutical item is not a combination item—is the same as the manner of administration set out in a determination under subsection 85(5) for the other pharmaceutical item; or
 (b) if the other pharmaceutical item is another combination item—is the same as the manner of administration set out in a determination under subsection 85(5) for the other combination item, to the extent that the manner of administration relates to the listed component drug.